Clinical trials: Candidiasis Vulvaginitis

Candidiasis Vulvaginitis

Efficacy Vulvovaginitis Candida

• Terminated
• Age: 18 years and older
• Phase 2
• Pill or oral medicine

To compare the therapeutic efficacy of 10 mg, 40 mg, 80 mg, 160 mg and 320 mg of albaconazole, as a single oral dose, in women affected by acute non-complicated vulvovaginitis due to Candida spp.

Trial name

NCT00199264

Testing

Albaconazole oral solution

Volunteers

60 people

Sponsor

J. Uriach and Company